|
US2006128806A1
|
|
Controlled release arginine alpha-ketoglutarate
|
|
WO2005039539A1
|
|
ORAL FORMULATION OF LIPID SOLUBLE THIAMINE, LIPOIC ACID, CREATINE DERIVATIVE, AND L-ARGININE α-KETOGLUTARATE
|
|
US2006062849A1
|
|
Oral formulation of creatine derivatives and method of manufacturing same
|
|
US2006062853A1
|
|
Treating neuromuscular disorders with an oral formulation of creatine derivatives
|
|
US2004259895A1
|
|
Oral formulation of lipid soluble thiamine and lipoic acid
|
|
US6905707B2
|
|
Controlled release arginine alpha ketoglutarate
|
|
AUPS243002A0
|
|
Therapeutic target and uses thereof
|
|
US6191162B1
|
|
Method of reducing serum glucose levels
|
|
US6197340B1
|
|
Controlled release lipoic acid
|
